Vitamin K (as Phytonadione)
Mechanism of Action +
### The Vitamin K Cycle and Gamma-Glutamyl Carboxylation
Phytonadione, or Vitamin K1, functions biochemically through a highly conserved oxidation-reduction loop known as the Vitamin K cycle. In its active, reduced form (vitamin K hydroquinone or KH2), phytonadione acts as an essential cofactor for the integral membrane enzyme gamma-glutamyl carboxylase (GGCX), located primarily in the rough endoplasmic reticulum. GGCX catalyzes the post-translational conversion of specific peptide-bound glutamic acid (Glu) residues into gamma-carboxyglutamic acid (Gla) residues.
During this carboxylation event, the reduced vitamin K hydroquinone is oxidized to vitamin K epoxide (KO). To maintain a continuous supply of the active cofactor, vitamin K epoxide must be recycled back to its hydroquinone form. This salvage pathway is driven by the enzyme vitamin K epoxide reductase complex subunit 1 (VKORC1), which first reduces the epoxide to a quinone (K), and subsequently reduces the quinone back to the active hydroquinone (KH2). This recycling mechanism is highly efficient, allowing a relatively small dietary intake of phytonadione to support massive amounts of protein carboxylation.
### Coagulation Cascade Activation
The most critical physiological role of phytonadione is the activation of hepatic coagulation factors. Seven specific proteins in the coagulation cascade require vitamin K-dependent carboxylation: procoagulant factors II (prothrombin), VII, IX, and X, as well as the anticoagulant proteins C, S, and Z. The formation of Gla domains on the N-termini of these proteins imparts a high affinity for calcium ions. When calcium binds to these Gla domains, it induces a conformational change that exposes hydrophobic regions of the protein, allowing these coagulation factors to anchor securely to the phospholipid membranes of activated platelets and endothelial cells. Without phytonadione-mediated carboxylation, these proteins are released into the bloodstream as des-gamma-carboxy (PIVKA) proteins, which are biologically inactive and result in severe coagulopathy and hemorrhage.
### Extrahepatic Gla Proteins: Bone and Vascular Health
Beyond the liver, phytonadione is transported to extrahepatic tissues where it activates other critical Gla-containing proteins. In bone tissue, osteoblasts synthesize osteocalcin (bone Gla protein). Vitamin K-dependent carboxylation of osteocalcin is required for it to bind to hydroxyapatite crystals in the bone matrix, facilitating proper bone mineralization and structural integrity.
In vascular smooth muscle and cartilage, phytonadione is involved in the carboxylation of Matrix Gla Protein (MGP). Fully carboxylated MGP is a potent inhibitor of soft tissue and vascular calcification. By binding calcium ions in the arterial walls, active MGP prevents the pathological deposition of calcium into blood vessels, thereby maintaining vascular elasticity and cardiovascular health. Another vitamin K-dependent protein, Growth Arrest-Specific 6 (Gas6), is involved in cell proliferation, apoptosis regulation, and phagocytosis, playing a role in nervous system health and inflammation control.
### Pharmacokinetics and Metabolism
As a fat-soluble vitamin, the absorption of phytonadione is highly dependent on normal biliary and pancreatic function. In the small intestine, dietary or supplemental phytonadione is incorporated into mixed micelles with the assistance of bile salts and dietary lipids. It is absorbed by enterocytes and packaged into chylomicrons, which are secreted into the lymphatic system before entering the systemic circulation.
Once in the bloodstream, chylomicron remnants are rapidly cleared by the liver, which is the primary storage and utilization site for Vitamin K1. Because of this rapid hepatic clearance, phytonadione is highly effective at supporting the synthesis of coagulation factors. However, it has a relatively short half-life in circulation compared to Menaquinone-7 (Vitamin K2).
Phytonadione is metabolized in the liver through omega-hydroxylation and subsequent beta-oxidation of its phytyl side chain, forming carboxylic acid derivatives. These metabolites are then conjugated with glucuronic acid and excreted primarily in the bile and feces, with a smaller fraction eliminated in the urine.
### Mechanism of Warfarin Antagonism
Warfarin and related coumarin-derivative anticoagulants exert their pharmacological effects by competitively inhibiting the VKORC1 enzyme. By blocking the reduction of vitamin K epoxide back to its active hydroquinone form, warfarin depletes the cellular pool of active vitamin K, halting the carboxylation of coagulation factors and inducing an anticoagulant state.
When high doses of phytonadione are administered to reverse warfarin toxicity, it bypasses the inhibited VKORC1 enzyme. At high concentrations, phytonadione can be reduced to its active hydroquinone form by an alternative, warfarin-resistant enzyme pathway (often identified as NAD(P)H:quinone oxidoreductase 1, or DT-diaphorase). This allows the resumption of gamma-glutamyl carboxylation and the rapid synthesis of functional clotting factors, effectively reversing the coagulopathy.
Is vitamin K the same as phytonadione? +
Are blueberries high in vitamin K? +
What happens if I take vitamin K every day? +
How much K2 is in eggs? +
What medications can you not take vitamin K with? +
What interacts with phytonadione? +
Why are parents refusing vitamin K for newborns? +
What is the negative effect of vitamin K? +
How long does it take for phytonadione to work? +
Can I take phytonadione on an empty stomach? +
What is the difference between Vitamin K1 and K2? +
Is phytonadione safe during pregnancy? +
Why is phytonadione prescribed for warfarin patients? +
Does phytonadione help with bruising? +
Can phytonadione lower blood pressure? +
What are the signs of vitamin K deficiency? +
How should phytonadione tablets be stored? +
Do sports supplements contain enough vitamin K? +
Everything About Vitamin K (as Phytonadione) Article
## Introduction to Phytonadione (Vitamin K1)
Phytonadione, universally known as Vitamin K1 or phylloquinone, is a fat-soluble vitamin that plays an indispensable role in human survival. Discovered in the early 20th century for its role in blood clotting (the 'K' stands for *Koagulation* in German), phytonadione is the primary dietary form of Vitamin K, found abundantly in leafy green vegetables like spinach, kale, and broccoli.
In clinical medicine, phytonadione is a powerhouse. It is the FDA-approved standard of care for treating vitamin K deficiency, reversing the effects of blood-thinning medications like warfarin, and preventing life-threatening bleeding in newborns. Beyond the emergency room, sports nutritionists and longevity researchers value phytonadione for its critical role in bone metabolism and cardiovascular health.
## The Biochemical Role of Vitamin K1
To understand why phytonadione is so important, you have to look at how the body handles calcium. Phytonadione acts as a biochemical 'on-switch' for a specific group of proteins known as Vitamin K-dependent proteins. It serves as a cofactor for an enzyme called gamma-glutamyl carboxylase.
This enzyme alters the structure of these proteins, giving them 'Gla domains'—specialized molecular claws that allow the proteins to grab onto calcium ions. Without phytonadione, these proteins are produced by the body but remain completely inactive. They float through the bloodstream unable to bind calcium, rendering them useless for blood clotting or bone building.
## Clinical Efficacy: Coagulation and Warfarin Reversal
The most well-known application of phytonadione is in the management of blood coagulation. The liver relies heavily on Vitamin K1 to produce active clotting factors II (prothrombin), VII, IX, and X.
For patients taking warfarin (a medication that purposefully blocks the body's recycling of Vitamin K to prevent blood clots), taking too much of the drug can lead to dangerously thin blood and a high risk of internal bleeding. In these scenarios, doctors prescribe oral or intravenous phytonadione (often under the brand name Mephyton) to rapidly reverse the drug's effects. According to clinical guidelines, an oral dose of 1 to 5 mg of phytonadione can safely lower a patient's International Normalized Ratio (INR) back to a safe range within 24 to 48 hours.
## Bone Mineral Density and Osteoporosis
While Vitamin K1 is famous for clotting, its role in bone health is equally profound. Examine.com gives Vitamin K a 'Grade B' for improving bone mineral density, backed by 13 clinical studies and multiple meta-analyses.
Bone tissue contains a protein called osteocalcin, which is responsible for binding calcium and integrating it into the bone matrix to make bones hard and dense. Just like the clotting factors in the liver, osteocalcin is entirely dependent on Vitamin K for activation. Supplementing with phytonadione (typically in doses ranging from 100mcg to 5mg daily) ensures that osteocalcin is fully carboxylated, leading to moderate improvements in bone strength and a reduced risk of osteoporosis, particularly in postmenopausal women.
## Cardiovascular Health: Keeping Calcium Out of Arteries
Calcium belongs in your bones, not in your blood vessels. When calcium deposits into arterial walls, it causes vascular calcification—a major risk factor for heart disease. Phytonadione helps prevent this by activating Matrix Gla Protein (MGP).
Active MGP acts as a calcium scavenger in the soft tissues, binding to stray calcium ions and preventing them from hardening the arteries. While Vitamin K2 (Menaquinone) is often heavily marketed for this specific benefit due to its longer half-life in the bloodstream, Vitamin K1 still plays a vital role in the overall activation of MGP and the maintenance of cardiovascular elasticity.
## What Phytonadione Does NOT Do
It is equally important to understand the limitations of phytonadione. According to comprehensive reviews by Examine.com, Vitamin K receives a 'Grade D' (indicating a lack of effect) for several heavily marketed claims. Clinical trials show that phytonadione supplementation does not significantly reduce C-reactive protein (a marker of inflammation), does not improve adiponectin levels (a metabolic hormone), does not lower blood pressure, and is ineffective at reducing skin bruising or accelerating surgical recovery times.
## Pharmacokinetics: Absorption and Metabolism
Because phytonadione is a fat-soluble vitamin, taking it on an empty stomach is a waste of money. Intestinal absorption requires the presence of dietary fats and bile salts to form micelles. Once absorbed, it is packaged into chylomicrons and transported directly to the liver.
This rapid hepatic uptake is why Vitamin K1 is so effective at supporting liver-based coagulation factors. However, it also means that K1 is cleared from the bloodstream relatively quickly compared to Vitamin K2. Furthermore, phytonadione is highly sensitive to light; pharmaceutical tablets must be kept in their original, light-resistant containers to prevent the active ingredient from degrading.
## Dosing Protocols and Guidelines
For general health and the prevention of deficiency, the Adequate Intake (AI) established by US standards is 120 mcg/day for adult males and 90 mcg/day for adult females.
For bone health support, clinical studies typically utilize doses between 100 mcg and 5 mg per day.
For the medical reversal of warfarin or the treatment of hypoprothrombinemia, physicians prescribe targeted doses ranging from 1 mg to 10 mg. It is critical to note that high doses of phytonadione (10 mg or more) can cause 'warfarin resistance' for a week or longer, making it difficult to re-establish therapeutic blood thinning if required.
## Safety, Toxicity, and Drug Interactions
Phytonadione is exceptionally safe for the general population. There is no established Upper Tolerable Limit (UL) because high doses of Vitamin K have not been shown to cause hypercoagulability (abnormal blood clotting) in healthy individuals. The body tightly regulates the coagulation cascade; once the available clotting factors are fully carboxylated, excess Vitamin K does not cause 'over-clotting.'
However, drug interactions are significant. Anyone taking warfarin or coumarin-based anticoagulants must strictly avoid Vitamin K supplements unless directed by their prescribing physician. Additionally, medications that block fat absorption—such as the weight-loss drug orlistat or bile acid sequestrants like cholestyramine—will severely impair the absorption of phytonadione. Patients with severe liver disease or biliary obstruction may also struggle to absorb oral phytonadione and often require co-administration with bile salt supplements.